KOR
ENG
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
지금 무엇을 찾으시나요?
추천검색어
Prescription Drugs
Over-the-Conunter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
한독은 인류의 건강과
삶의 질을 위해 노력합니다.
한독과 함께 변화하는 삶
일상건강에서 만나보세요
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
KR
EN
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
궁금한 부분이 있으신가요?
CONTACT
한독과 함께 변화하는 삶
일상건강
Handok’s Collaborator, Compass Therapeutics, Announces Positive Topline Results from Phase 2/3 of Tovecimig (HDB001A)
Handok Affiliate Rezolute's Congenital Hyperinsulinism Treatment RZ358 Designated as a Breakthrough Therapy by the FDA
Handok Begins Domestic Sales of Hyperlipidemia Treatment Lipidil from Korea Abbott
Handok Affiliate Rezolute's RZ358 Designated as an Orphan Drug by the FDA for the Treatment of Hypoglycemia Due to Tumor-Induced Hyperinsulinism
Handok Hosts 70th Anniversary R&D Symposium on Open Innovation
Handok's Affiliate Rezolute Advances Development of Congenital Hyperinsulinism Treatment (RZ358), Confirming Safety and Proceeding with Phase 3 Trials in the U.S. Without Age Restrictions
Handok's Non-Small Cell Lung Cancer Drug Development Project Selected for Ministry of Trade, Industry and Energy's Global Industry Technology Cooperation Center Program
프레스룸
총
1069
개의 소식들이 있습니다
한독, 2025 자율형공장 구축 지원사업 선정으로 스마트공장 경쟁력 강화
2025.06.26
한독, 2025 스마트 생태공장 구축 사업 선정으로 친환경 경영 강화
2025.06.19
[중앙일보 - Health&] 당뇨 없어도 혈당은 치솟는다…24시간 센서로 본 몸의 변화
2025.06.09
한독, ‘속 편한 연구소 in 충북’ 팝업 전시 성황리에 마쳐
2025.06.09
[데일리팜] 훼스탈 팝업스토어, 제품 인지도·소비자 로열티 UP
2025.06.09
[이투데이] 의약에서 힐링까지…‘속 편해지는 공간’ 한독 훼스탈 팝업 [가보니]
2025.06.05
[팜뉴스] [현장] 한독 국민 소화제 '훼스탈'과 문화유산이 만났다
2025.06.05
한독, 충청북도와 지역사회 상생을 위한 협약 체결
2025.06.05
[쿠키뉴스]자립도 혈당관리도 힘든 스무살 1형 당뇨 환자들…CGM으로 어려움 던다
2025.05.28
PREV
1
2
3
4
5
6
7
8
9
10
NEXT